Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IRIS-COV

Financiado

Cerrado

Market Release of a Portable Device for COVID 19 at the Point of Care a Global...

Market Release of a Portable Device for COVID 19 at the Point of Care a Global Diagnostics Approach The current pandemic of the coronavirus, reported first on 31st December 2019 in China, has produced a global alert of unprecedented nature. From the beginning, immediate actions have been put in place by all relevant stakeholders... ver más

30/04/2022

FOUNDATION FOR RES...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

IDRYMA TECHNOLOGIAS KAI EREVNAS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-04-30

SC1-PHE-CORONAVIRUS-2020-2B: Medical technologies, Digital tools...

I+D

Cerrada hace 4 años

0% 78% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

FOUNDATION FOR RESEARCH AND...

252.00K€ | Lider

Kiara Health

286.56K€ | Participante

INSERM

146.00K€ | Participante

BIOPIX DNA TECHNOLOGY S.A.

520.63K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RAPID-COVID Robust Automation and Point of Care IDentification of COVID 3M€ Cerrado

CORONADX Three Rapid Diagnostic tests Point of Care for COVID 19 Co... 3M€ Cerrado

DECISION A minituarized disposable molecular diagnostics platform for... 4M€ Cerrado

PID2020-118904RB-C22 DESARROLLO DE TESTS RAPIDOS Y ULTRASENSIBLES PARA INFECCIONE... 74K€ Cerrado

PID2020-116728RB-I00 DESARROLLO DE BIOSENSORES DE ULTIMA GENERACION PARA EL DIAGN... 132K€ Cerrado

Duración del proyecto: 18 meses Fecha Inicio: 2020-10-06
Fecha Fin: 2022-04-30

Líder del proyecto

IDRYMA TECHNOLOGIAS KAI EREVNAS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The current pandemic of the coronavirus, reported first on 31st December 2019 in China, has produced a global alert of unprecedented nature. From the beginning, immediate actions have been put in place by all relevant stakeholders, i.e., local health departments, governments, pharmaceutical companies, global organisations etc., to address the problem as quickly as possible and control the spread of the disease. Large scale testing of symptomatic and asymptomatic patients/citizens has been one of the most effective measures taken by several countries, combined with isolation and tracking. Today, after six months from the outbreak, the deaths continue to rise with over 200 affected countries. Fear of a new wave of the pandemic together with the ongoing cases worldwide make the need for developing rapid and accurate diagnostic tools for COVID-19 a global priority, as declared by the WHO. The current consortium aims to join forces in the battle against the coronavirus by producing mature and robust solutions with immediate impact. The proposal is built around the implementation of an existing and patented device and methodology based on isothermal LAMP amplification and real time quantitative colorimetric detection. This mature methodology, currently of a technology readiness level of 7, has already been proven to be able to detect SARS-CoV-2 in patients’ samples with 97.4% sensitivity and 100% specificity. The main objectives of this proposal are thus the immediate deployment of the device following clinical validation and fast track certification. Arrangements for the large-scale production of the device and reagents will take place in parallel, followed by the provision of a full medical certification for COVID-19 and flu detection directly in crude samples and at the point-of-care. Global uptake of the two certified products together with global sharing of the project results are important deliverables of the proposal for the current and future epidemics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores